Systems and methods for measuring cell signaling protein activity
US-2024230643-A9 · Jul 11, 2024 · US
US2016257966A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016257966-A1 |
| Application number | US-201615057551-A |
| Country | US |
| Kind code | A1 |
| Filing date | Mar 1, 2016 |
| Priority date | Mar 4, 2015 |
| Publication date | Sep 8, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein are a transformed Synechococcus elongatus strain having improved capability of producing acetone and a method for producing acetone and a method for removing carbon dioxide using the same. In an aspect, the transformed Synechococcus elongatus strain of the present disclosure can produce acetone with high selectivity using carbon dioxide as a carbon source. The present disclosure is economical because the Synechococcus elongatus strain can economically produce high value-added acetone using carbon dioxide existing in the atmosphere as a carbon source without requiring an additional catalytic reaction. Also, the present disclosure is environment-friendly because carbon dioxide in the atmosphere can be removed or reduced using the microorganism.
Opening claim text (preview).
What is claimed is: 1 . A Synechococcus elongatus strain having an acetone selectivity, defined as the molar ratio of acetone in the total product produced by the strain, of 0.8 or greater under a condition of 30° C. and 5% carbon dioxide. 2 . The strain according to claim 1 , wherein the strain comprises: one or more selected from a group consisting of an acetyl-CoA transferase gene and an acetyl-CoA synthase gene; an acetoacetyl-CoA transferase gene; and an acetoacetate decarboxylase gene. 3 . The strain according to claim 2 , wherein the acetyl-CoA transferase gene comprises a sequence of SEQ ID NO 1, the acetyl-CoA synthase gene comprises a sequence of SEQ ID NO 2, the acetoacetyl-CoA transferase gene comprises a sequence of sequence of SEQ ID NO 3 or SEQ ID NO 4, and the acetoacetate decarboxylase gene comprises a sequence of sequence of SEQ ID NO 5. 4 . The strain according to claim 1 , wherein the strain is one transformed with a vector comprising: a gene comprising a sequence derived from an atoB gene or an nphT7 gene; a gene comprising a sequence derived from an atoDA gene or a cftAB gene; and a gene comprising a sequence derived from an adc gene. 5 . The strain according to claim 4 , wherein the strain is Synechococcus elongatus PCC7942 transformed with the vector. 6 . The strain according to claim 4 , wherein the vector further comprises: a pUC replication origin as a replication origin; neutral sites located upstream and downstream of the replication origin; a spectinomycin resistance gene as a selection marker; a repressor selected from a group consisting of a lac I repressor, a tetR repressor and an AraC repressor; a promoter selected from a group consisting of a trc promoter, a tetA promoter or a modified tetA promoter, a BAD promoter and a cbbL promoter; and a BglII site, a BamHI site, an EcoRI site and an XhoI site as restriction enzyme sites. 7 . The strain according to claim 6 , wherein the gene comprising a sequence derived from the atoB gene, the gene comprising a sequence derived from the nphT7 gene, the gene comprising a sequence derived from the atoDA gene, the gene comprising a sequence derived from the cftAB gene and the gene comprising a sequence derived from the adc gene are located between the BglII site and the BamHI site. 8 . The strain according to claim 4 , wherein the vector comprises a sequence from SEQ ID NOS 6-9. 9 . The strain according to claim 3 , wherein the strain is a Synechococcus elongatus strain of accession number KCTC12758BP, KCTC12759BP, KCTC12760BP or KCTC12761BP. 10 . The strain according to claim 1 , wherein the strain absorbs and fixes carbon dioxide.
Related publications grouped by family.
Answers are generated from the same data shown on this page.